After having mentored Eukarÿs during the Biotools Innovator acceleration program, Nicole Faust and Bryan Poltilove join the company as strategic advisors.
As former CSO and CEO of CEVEC (acquired in 2024 by Cytiva, Danaher group), a world first technology cell line company, Nicole brings both her technical capabilities in cell line engineering and her successful experience in building a leader of the biomanufacturing technology.
As former VP/GM with Thermo Fisher and Operating Partner with BroadOak Capital, Bryan brings a rare combination of experience in business leadership, strategy, and investing in the field of biomanufacturing technology.
